(Q40560533)

English

Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1.

scientific article published on May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1. (English)

1 reference

Europe PubMed Central

21 September 2017

1 reference

based on heuristic

inferred from title

Bovine herpesvirus 1

object named as

bovine herpesvirus 1

1 reference

based on heuristic

inferred from title

5

object named as

Etienne Thiry

1 reference

Europe PubMed Central

21 September 2017

author name string

Sacha Gogev

1

1 reference

Europe PubMed Central

21 September 2017

Katalin de Fays

2

1 reference

Europe PubMed Central

21 September 2017

Marie-France Versali

3

1 reference

Europe PubMed Central

21 September 2017

Sandrine Gautier

4

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

22

1 reference

Europe PubMed Central

21 September 2017

1946-1953

1 reference

Europe PubMed Central

21 September 2017

15-16

1 reference

Europe PubMed Central

21 September 2017

Clearance characteristics of chitosan based formulations in the sheep nasal cavity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Transport of drugs from the nasal cavity to the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Chitosan and its use as a pharmaceutical excipient

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Chitosan as a novel nasal delivery system for peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Enhancement of nasal absorption of insulin using chitosan nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Advances in the development and evaluation of bovine herpesvirus 1 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Antibody response to glycoprotein E after bovine herpesvirus type 1 infection in passively immunised, glycoprotein E-negative calves

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Oral drug absorption enhancement by chitosan and its derivatives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.011

7 January 2021

Identifiers

10.1016/J.VACCINE.2003.11.011

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40560533&oldid=1799848873"